Pain Gate Ddsc 018 -

[ Mechanical Stimulus (Touch/Rubbing) ] ---> Large A-Beta Fibers (+) │ ▼ [ Substantia Gelatinosa ] (Inhibitory Interneuron) │ ▼ (Inhibits / Closes Gate) [ Noxious Stimulus (Injury/Pain) ] ---------> Small A-Delta & C Fibers (+) ──► [ Transmission (T) Cell ] ──► To Brain

Do NOT use the DDSC 018 on patients with:

Recently, a new player has entered the field of pain management: the DDSC 018. The DDSC 018 is a novel, non-invasive device that uses advanced technology to stimulate Aδ fibers and close the pain gate. By doing so, it aims to provide effective pain relief for individuals suffering from chronic pain. pain gate ddsc 018

For severe, intractable chronic pain, surgeons implant Spinal Cord Stimulators. These devices deliver micro-electrical pulses directly to the dorsal columns of the spinal cord. This advanced application acts as a permanent, adjustable digital block on the DDSC-018 pathway, offering significant relief to patients who have failed to find comfort through conventional medications. Share public link

Introduction Pain remains a leading cause of disability worldwide. Gate-control theory — the modulation of nociceptive transmission at the dorsal horn through competing inputs — established a physiological basis for numerous neuromodulatory therapies (e.g., TENS, spinal cord stimulation). DDSc 018 is presented here as a focused modality designed to engage spinal inhibitory circuitry and descending control to reduce pain perception with a programmable, multimodal stimulus and targeted patient-selection strategy. [ Mechanical Stimulus (Touch/Rubbing) ] ---> Large A-Beta

This mechanism explains some common everyday experiences. For instance, when you hit your shin, your immediate reaction is to rub the area. The gentle, non-painful sensation of rubbing helps "close the gate" to the sharper, more intense pain signals, reducing the overall pain you perceive.

Suggested stimulation parameters (initial, to be optimized per patient): Share public link Introduction Pain remains a leading

The DDSC 018 is indicated for the symptomatic relief and management of: